VESGEN Mapping of Bioactive Protection against Intestinal Inflammation: Application to Human Spaceflight and ISS Experiments by Parsons-Wingerter, P. A. et al.
VESGEN Mapping of Bioactive Protection against Intestinal Inflammation: Application to 
Human Spaceflight and ISS Experiments. PA Parsons-Wingerter', X Chen2, CP Kelly2, HC 
Reinecker, 1NASA-GRC Research & Technology, 2 Division of Gastroenterology, Beth Israel 
Deaconess Medical Center, 3Division of Gastroenterology, Massachusetts General Hospital and 
Harvard Medical School. 
Challenges to successful space exploration and colonization include adverse 
physiological reactions to micro gravity and space radiation factors. Constant remodeling of the 
microvasculature is critical for tissue preservation, wound healing, and recovery after ischemia. 
Regulation of the vascular system in the intestine is particularly important to enable nutrient 
absorption while maintaining barrier function and mucosal defense against micro biota. Although 
tremendous progress has been made in understanding the molecular circuits regulating 
neovascularization, our knowledge of the adaptations of the vascular system to environmental 
challenges in the intestine remains incomplete. This is in part because of the lack of methods to 
observe and quantify the complex processes associated with vascular responses in vivo. 
Developed by GRC as a mature beta version, pre-release research software, VESsel GENeration 
Analysis (VESGEN) maps and quantifies the fractal-based complexity of vascular branching for 
novel insights into the cytokine, transgenic and therapeutic regulation of angiogenesis, 
lymphangiogenesis and microvascular remodeling. Here we demonstrate that VESGEN can be 
used to characterize the dynamic vascular responses to acute intestinal inflammation and 
mucosal recovery from in vivo confocal microscopic 3D image series. We induced transient 
intestinal inflammation in mice by DSS treatment and investigated whether the ability of the 
pro biotic yeast Saccharomyces boulardii (Sb) to protect against intestinal inflammation was due 
to regulation of vascular remodeling. A primary characteristic of inflammation is excessive 
neovascularization (angiogenesis) resulting in fragile vessels prone to bleeding. Morphological 
parameters for triplicate specimens revealed that Sb treatment greatly reduced the inflammatory 
response of vascular networks by an average of 78%. This resulted from Sb inhibition of vascular 
endothelial growth factor receptor signaling, a major angiogenesis signaling pathway. It needs to 
be determined whether pro biotic yeast represents a promising approach to GI protection in space. 
GRC performed only the VESGEN post-testing analysis. 
NASA GRC IR&D04-54/2010 TTP Fund (PPW); NIH DK-068181/DK-043351/AI-093588 
(HCR), DK-033506 (HCR/CPK). 
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Challenges to successful space exploration and colonization include adverse physiological reactions to 
microgravity and space radiation factors. Constant remodeling of the microvasculature is critical for tissue 
preservation, wound healing, and recovery after ischemia. Regulation of the vascular system in the intestine is 
particularly important to enable nutrient absorption while maintaining barrier function and mucosal defense against 
microbiota. Although tremendous progress has been made in understanding the molecular circuits regulating 
neovascularization, our knowledge of the adaptations of the vascular system to environmental challenges in the 
intestine remains incomplete. This is in part because of the lack of methods to observe and quantify the complex 
processes associated with vascular responses in vivo. 
Developed by GRC as a mature beta version, pre-release research software, VESsel GENeration Analysis 
(VESGEN) maps and quantifies the fractal-based complexity of vascular branching for novel insights into the 
cytokine, transgenic and therapeutic regulation of angiogenesis, lymphangiogenesis and microvascular 
remodeling. Here we demonstrate that VESGEN can be used to characterize the dynamic vascular responses to 
acute intestinal inflammation and mucosal recovery from in vivo confocal microscopic 3D image series. We 
induced transient intestinal inflammation in mice by DSS treatment and investigated whether the ability of the 
probiotic yeast Saccharomyces boulardii ( Sb) to protect against intestinal inflammation was due to regulation of 
vascular remodeling. A primary characteristic of inflammation is excessive neovascularization (angiogenesis) 
resulting in fragile vessels prone to bleeding. Morphological parameters for triplicate specimens revealed that Sb 
treatment greatly reduced the inflammatory response of vascular networks by an average of 78o/o. This resulted 
from Sb inhibition of vascular endothelial growth factor receptor signaling, a major angiogenesis signaling 
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space. GRC performed only the VESGEN post-testing analysis. NASA GRC IR&D04-54/2010 TTP Fund (PPW); 
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Microvascular Remodeling and Angioger~esis 
Fundamental to healthy physiology, disease progression and successful 
prophylactic/therapeutic strategies on Earth and in Space 
Dynamic Microvascular Remodeling in Gl Tract 
• Permeability enables nutrient absorption 
• Yet must provide barrier protection & mucosal defense against microbiota 
Analysis Methods Lacking for Remodeling Microvasculature 
VESsel GENeration Analysis (VESGEN) Software 
• Innovative research discovery tool for informative mapping and 
quantification of vascular remodeling throughout the body 
• Retina as window to the body 
• Leaf venation remodeling in ISS-utilized Arabidopsis thaliana 
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VESGEN 
Mapping and Quantification 
of Branching Vascular Pattern 
Human Retina Vascular Trees Mouse Retina 
Human Retina 
Avian CAM, Yolksac and Mouse/Avian Coronary Vessels 
Vascular Networks 
Mouse Intestinal Inflammation, CAM Lymphatic Vessels 
Vascular Tree-Network Composites 
Mouse Postnatal Retina, Early Embryonic Coronary Vessels 
Leaf Venation Patterns in Arabidopsis thaliana 
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Methods for Experimental Model of Gl Inflammation 
by VESGEN Vascular Analysis 
Oral administration of probiotic yeast Saccharomyces boulardii (Sb) 
for protection against DSS colitis in mice 
confocal 
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Chen X, Yang G, Song JH, Xu H, LiD, Yang X, Zeng H, Parsons-Wingerter P, Reinecker HC & Kelly CP, in progress 
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Complex System Results for Gl Vascular Networks by VESGEN: 
Probiotic Sb Restores Normal Vascular Architecture by 78°/o 
Vascular Control Probiotic Inflammation PARAMETER 
Parameter Sb CONCLUSION 
Vessel SIMPLE Parameter 
Diameter (~) 16.4 ± 0.5 17.4 ± 1.4 17.6±0.7 not different 
Vascular COMPLEX Parameter 
Area Fraction 0.272 ± 0.020 0.293 ± 0.040 0.409 ± 0.072 significantly different 
Branch Points COMPLEX 
326 ± 32 452 ± 25 981 ± 259 significantly different 
End Points COMPLEX 
134 ± 5 266 ± 41 548 ± 101 significantly different 
Avascular Spaces COMPLEX 
100 ± 14 104 ± 8 240 ± 79 significantly different 
Triplicate mean ± std dev 
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Mapping of Progressive Blinding Human Retinopathy by VESGEN 
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Conclusions 
• By VESGEN mapping and quantification, probiotic yeast protected 
against Gl vascular inflammation by 78% in vivo 
•Probiotic yeast offers a promising approach to Gl protection in space, perhaps 
against radiation and generalized inflammation as well as infectious disease 
•Innovative VESGEN application to Gl inflammation .:_ building on previously 
published work for vascular tissues including human and rodent retina; avian 
CAM, avian and rodent coronary vessels and remodeling leaf venation patterns 
in Arabidopsis thaliana 
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